Arsenate suppression of human keratinocyte programming

Mutation Research - Reviews in Mutation Research

Volumn 386, Issue 3, 1997, Pages 253-261

  Kachinskas, Donna J ^a   Qin, Qin ^a   Phillips, Marjorie A ^a   Rice, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP1; AP2; Chromate; Involucrin; Phorbol ester; Vanadate

Indexed keywords

ARSENATE SODIUM; CELL MARKER; DNA; FILAGGRIN; INVOLUCRIN; KERATIN; LORICRIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; POTASSIUM CHROMATE; PROLINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; VANADATE SODIUM;

CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

EID: 0030872070     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(97)00015-X     Document Type: Review

References (51)

1. WHO (1980) in: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Metal and Metallic Compounds, International Agency for Research on Cancer, Lyon, pp. 101-114.
2. H.-Y. Chiou, Y.-M. Hsueh, K.-F. Liaw, S.-F. Horng, M.-H. Chiang, Y.-S. Pu, J.S.-N. Lin, C.-H. Huang, C.-J. Chen, Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan, Cancer Res. 55 (1995) 1296-1300.
3. T. Tsuda, A. Babazono, E. Yamamoto, N. Kurumatani, Y. Mino, T. Ogawa, Y. Kishi, H. Aoyama, Ingested arsenic and internal cancer: a historical cohort study followed for 33 years, Am. J. Epidemiol. 141 (1995) 198-209.
4. W.P. Tseng, H.M. Chu, S.W. How, J.M. Fang, C.S. Lin, S.W. Yeh, Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan, J. Natl. Cancer Inst. 40 (1968) 453-463.
5. K.G. Brown, K.E. Boyle, C.W. Chen, H.J. Gibb, A dose-response analysis of skin cancer from inorganic arsenic in drinking water, Risk Anal. 9 (1989) 519-528.
6. A.H. Smith, C. Hopenhayn-Rich, M.N. Bates, H.M. Goeden, I. Hertz-Picciotto, H.M. Duggan, R. Wood, M.J. Kosnett, M. Smith, Cancer risks from arsenic in drinking water, Environ. Health Perspect. 97 (1992) 259-267.
7. Marcus, W.L. and A.S. Rispin (1988) Threshold carcinogenicity using arsenic as an example, in: C.R. Cothern and M.A. Mehlman (Eds.), Advances in Modern Environmental Toxicology: Risk Assessment and Risk Management of Industrial and Environmental Chemicals, Princeton Scientific Publishing, Princeton, pp. 133-158.
8. K.G. Brown, C.-J. Chen, Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan, Risk Anal. 15 (1995) 475-484.
9. Petito, C.T. and B.D. Beck (1991) Evaluation of evidence of nonlinearities in the dose-response curve for arsenic carcinogenesis, in: D.E. Hemphill and E.R. Cothern (Eds.), Trace Substances in Environmental Health, pp. 143-176.
10. E. Fuchs, Epidermal differentiation: the bare essentials, J. Cell Biol. 111 (1990) 2807-2814.
11. V.H. Ferm, S.J. Carpenter, Malformations induced by sodium arsenate, J. Reprod. Fertil. 17 (1968) 199-201.
12. D.J. Kachinskas, M.A. Phillips, Q. Qin, J.D. Stokes, R.H. Rice, Arsenate perturbation of human keratinocyte differentiation, Cell Growth Differ. 5 (1994) 1235-1241.
13. J.G. Rheinwald, M.A. Beckett, Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous carcinomas, Cancer Res. 41 (1981) 1657-1663.
14. M.A. Phillips, R.H. Rice, Convergent differentiation in cultured rat cells from nonkeratinizing epithelia: keratinocyte character and intrinsic differences, J. Cell Biol. 97 (1983) 686-691.
15. B.L. Allen-Hoffman, J.G. Rheinwald, Polycyclic aromatic hydrocarbon mutagenesis of human epidermal keratinocytes in culture, Proc. Natl. Acad. Sci. USA 81 (1984) 7802-7806.
16. P. Chomczynski, N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
17. A.P. Feinberg, B. Vogelstein, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity, Anal. Biochem. 132 (1983) 6-13.
18. A.R. Brasier, J.E. Tate, J.F. Haebner, Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines, BioTechniques 7 (1989) 1116-1122.
19. Gorman, C.M. (1985) High efficiency gene transfer into mammalian cells, in: D.M. Glover (Eds.), DNA Cloning, A Practical Approach, IRL Press, Oxford, pp. 143-190.
20. R.L. Eckert, H. Green, Structure and evolution of the human involucrin gene, Cell 46 (1986) 583-589.
21. A.L. Tyner, E. Fuchs, Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis, J. Cell Biol. 103 (1986) 1945-1955.
22. R. Lersch, E. Fuchs, Sequence and expression of a type II keratin, K5, in human epidermal cells, Mol. Cell. Biol. 8 (1988) 486-493.
23. V. Stellmach, A. Leask, E. Fuchs, Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells, Proc. Natl. Acad. Sci. USA 88 (1991) 4582-4586.
24. R.B. Presland, P.V. Haydock, P. Fleckman, W. Nirunsuksiri, B.A. Dale, Characterization of the human profilaggrin gene, J. Biol. Chem. 267 (1992) 23772-23781.
25. T. Magnaldo, F. Bernerd, D. Asselineau, M. Darmon, Expression of loricrin is negatively controlled by retinoic acid in human epidermis reconstructed in vitro, Differentiation 49 (1992) 39-46.
26. T. Williams, A. Admon, B. Luscher, R. Tjian, Cloning and expression of AP-2, a cell type-specific transcription factor that activates inducible enhancer elements, Genes Dev. 2 (1988) 1557-1569.
27. G. An, T.H.M. Huang, J. Tesfaigzi, J. Garcia-Heras, D.H. Ledbetter, D.M. Carlson, R. Wu, An unusual expression of a squamous cell marker, small proline rich protein (spr1) gene, in tracheobronchial epithelium: differential regulation and gene mapping. Am. J. Resp. Cell Mol. Biol. 7 (1992) 104-111.
28. B.E. Stewart, R.H. Rice, Differentiation-associated expression of the proto-oncogenc pim-1 in cultured human keratinocytes, J. Invest. Dermatol. 105 (1995) 699-703.
29. R.H. Rice, X. Rong, R. Chakravarty, Suppression of keratinocyte differentiation in SCC-9 human squamous carcinoma cells by benzo(a)pyrene, 12-O-tetradecanoylphorbol-13-acetate and hydroxyurea, Carcinogenesis 9 (1988) 1885-1890.
30. S. Galvin, C. Loomis, M. Manabe, D. Dhouailly, T.-T. Sun, The major pathways of keratinocyte differentiation as defined by keratin expression: an overview, Adv. Dermatol. 4 (1989) 277-300.
31. N.L. Parenteau, A. Pilato, R.H. Rice, Induction of keratinocyte type 1 transglutaminase in epithelial cells of the rat, Differentiation 33 (1986) 130-141.
32. L. Mariniello, Q. Qin, B.A. Jessen, R.H. Rice, Keratinocyte transglutaminase promoter analysis. Identification of a functional response element, J. Biol. Chem. 270 (1995) 31358-31363.
33. J.M. Carroll, L.B. Taichman, Characterization of the human involucrin promoter using a transient beta-galactosidase assay, J. Cell Sci. 103 (1992) 925-930.
34. J.M. Carroll, K.M. Albers, J.A. Garlick, R. Harrington, L.B. Taichman, Tissue-and stratum-specific expression of the human involucrin promoter in transgenic mice, Proc. Natl. Acad. Sci. USA 90 (1993) 10270-10274.
35. M.F. Denning, A.A. Dlugosz, E.K. Williams, Z. Szallasi, P.M. Blumberg, S.H. Yuspa, Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium, Cell Growth Differ. 6 (1995) 149-157.
36. E.J. Yurkow, G. Kim, Effects of chromium on basal and insulin-induced tyrosine phosphorylation in H4 hepatoma cells: comparison with phorbol-12-myristate-13-acetate and sodium orthovanadate, Mol. Pharmacol. 47 (1995) 686-695.
37. M.D. Cohen, B. Kargacin, C.B. Klein, M. Costa, Mechanisms of chromium carcinogenicity and toxicity, Crit. Rev. Toxicol. 23 (1993) 255-281.
38. J. Ye, X. Zhang, H.A. Young, Y. Mao, X. Shi, Chromium (VI)-induced nuclear factor-kB activation in intact cells via free radical reactions, Carcinogenesis 16 (1995) 2401-2405.
39. J.F. Welter, J.F. Crish, C. Agarwal, R.L. Eckert, Fos-related antigen (Fra-1), jun B, and jun D activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity, J. Biol. Chem. 270 (1995) 12614-12622.
40. E. Lopez-Bayghen, A. Vega, A. Cadena, S.E. Granados, L.F. Jave, P. Gariglio, L.M. Alvarez-Salas, Transcriptional analysis of the 5′-noncoding region of the human involucrin gene, J. Biol. Chem. 271 (1996) 512-520.
41. H. Takahashi, H. Iizuka, Analysis of the 5′-upstream promoter region of human involucrin gene: activation by 12-O-tetradecanoylphorbol-13-acetate. J. Invest. Dermatol. 100 (1993) 10-15.
42. A. Gandarillas, F.M. Watt, The 5′ noncoding region of the mouse involucrin gene: comparison with the human gene and genes encoding other cornified envelope precursors, Mammalian Genome 6 (1995) 680-682.
43. A. Leask, C. Byrne, E. Fuchs, Transcription factor AP-2 and its role in epidermal-specific gene expression, Proc. Natl. Acad. Sci. USA 88 (1991) 7948-7952.
44. M. Ohtsuki, S. Flanagan, I.M. Freedberg, M. Blumenberg, A cluster of five nuclear proteins regulates keratin gene transcription, Gene Expression 3 (1993) 201-213.
45. D. DiSepio, A. Jones, M.A. Longley, D. Bundman, J.A. Rothnagel, D. Roop, The proximal promoter of the mouse loricrin gene contains a functional AP-1 element and directs keratinocyte-specific but not differentiation-specific expression, J. Biol. Chem. 270 (1995) 10792-10799.
46. S.P.M. Reddy, Y.-J. Chuu, P.N. Lao, J. Donn, D.K. Ann, R. Wu, Expression of human squamous cell differentiation marker, SPR1, in tracheobronchial epithelium depends on JUN and Tre motifs, J. Biol. Chem. 270 (1995) 26451-26459.
47. B. Lu, J.A. Rothnagel, M.A. Longley, S.Y. Tsai, D.R. Roop, Differentiation-specific expression of human keratin 1 is mediated by a composite AP-1/steroid hormone element, J. Biol. Chem. 269 (1994) 7443-7449.
48. P. Angel, M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, H.J. Rahmsdorf, C. Jonat, P. Herrlich, M. Karin, Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor, Cell 49 (1987) 729-739.
49. T.C. Lee, N. Tanaka, P.W. Lamb, T.M. Gilmer, J.C. Barrett, Induction of gene amplification by arsenic, Science 241 (1988) 79-81.
50. F. Bertolero, G. Pozzi, E. Sabbioni, U. Saffioti, Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation, Carcinogenesis 8 (1987) 803-808.
51. S. Yamamoto, Y. Konishi, T. Matsuda, T. Murai, M.-A. Shibata, I. Matsui-Yuasa, S. Otani, K. Kuroda, G. Endo, S. Fukushima, Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens, Cancer Res. 55 (1995) 1271-1276.